Patient with hepatic cirrhosis: management strategy according to national clinical guidelines and real clinical practice. Results of a retrospective cohort study
- Авторлар: Korochanskaya N.V1,2, Durleshter V.M1,2, Kovalevskaya O.V2, Basenko M.A1,2, Serikov S.S1,2
-
Мекемелер:
- Kuban State Medical University
- Regional Clinical Hospital № 2
- Шығарылым: Том 28, № 2 (2021)
- Беттер: 78-83
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313084
- DOI: https://doi.org/10.18565/pharmateca.2021.2.78-83
- ID: 313084
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
N. Korochanskaya
Kuban State Medical University; Regional Clinical Hospital № 2
Email: nvk-gastro@mail.ru
Krasnodar, Russia
V. Durleshter
Kuban State Medical University; Regional Clinical Hospital № 2Krasnodar, Russia
O. Kovalevskaya
Regional Clinical Hospital № 2Krasnodar, Russia
M. Basenko
Kuban State Medical University; Regional Clinical Hospital № 2Krasnodar, Russia
S. Serikov
Kuban State Medical University; Regional Clinical Hospital № 2Krasnodar, Russia
Әдебиет тізімі
- Hudson B., Round J., Georgeson B., et al. Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England. Lancet Gastroenterol Hepatol. 2018;3:95-103. doi: 10.1016/S2468- 1253(17)30362-X.
- Tapper E.B., Halbert B., Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study. Clin Gastroenterol Hepatol. 2016;14:1181- 1188, e1182. doi: 10.1016/j.cgh.2016.04.009
- Ивашкин В.Т., Маевская М.В., Павлов Ч.С., и др. Клинические рекомендации Российского общества по изучению печении Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, коло-проктологии. 2016;26(4):71-102
- European Association for the Study of the Liver; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-60. Doi: W.1016/j.jhep.2018.03.024.
- Le S, Spelman T, Chong C.P, et al. Could adherence to quality of care indicators for hospitalized patients with cirrhosis-related ascites improve clinical outcomes? Am J Gastroenterol. 2016;111(1):87-92. doi: 10.1038/ajg.2015.402.
- Landis C.S, Ghabril M., Rustgi V, et al. Prospective multicenter observational study of overt hepatic encephalopathy. Dig Dis Sci. 2016;61:1728-1734.
- Wooller K.D., Yelle D, Fisher S., et al. Adherence to quality indicators and hospital outcomes for patients with decompensated cirrhosis: An observational study. Canadian Liv J. 2020;4:348-57. doi: 10.3138/canlivj-2020-0003.
- Polis S., Zang L., Mainali B., et al. Factors associated with medication adherence in patients living with cirrhosis. J Clin Nurs. 2016;25:204-12. doi: 10.1111/jocn.13083.
- Garcia-Tsao G., Abraldes J.G., Berzigotti A., Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310-35. Doi: 10.1002/ hep.28906.
- Shukla R., Kramer J., Cao Y, et al. Risk and predictors of variceal bleeding in cirrhosis patients receiving primary prophylaxis with non-selective beta-blockers. Am J Gastroenterol. 2016;111:1778-1787. doi: 10.1038/ajg.2016.440.
- Bajaj J.S., Reddy K.R., Tandon P, et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200-8. doi: 10.1002/hep.28414.
- Tapper E.B., Finkelstein D. Mittleman M.A., et al. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;14(5):753-59. doi: 10.1016/j.cgh.2015.08.041. Medline: 26407750.
- Sobotka L.A., Modi R.M., Vijayaraman A., et al. Paracentesis in cirrhotics is associated with increased risk of 30-day readmission. World J Hepatol. 2018;10(6):425-32. Doi: 10.4254/ wjh.v10.i6.425. Medline: 29988878.